{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T10:32:34Z","timestamp":1782901954360,"version":"3.54.5"},"reference-count":110,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,7,9]],"date-time":"2020-07-09T00:00:00Z","timestamp":1594252800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,7,9]],"date-time":"2020-07-09T00:00:00Z","timestamp":1594252800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100007393","name":"French Muscular Dystrophy Association","doi-asserted-by":"publisher","award":["18916"],"award-info":[{"award-number":["18916"]}],"id":[{"id":"10.13039\/100007393","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Ph.D. fellowships from the Belgian F.R.S-FNRS"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Intramuscular injection and electroporation of naked plasmid DNA (IMEP) has emerged as a potential alternative to viral vector injection for transgene expression into skeletal muscles. In this study, IMEP was used to express the <jats:italic>DUX4<\/jats:italic> gene into mouse <jats:italic>tibialis anterior<\/jats:italic> muscle. <jats:italic>DUX4<\/jats:italic> is normally expressed in germ cells and early embryo, and silenced in adult muscle cells where its pathological reactivation leads to Facioscapulohumeral muscular dystrophy. <jats:italic>DUX4<\/jats:italic> encodes a potent transcription factor causing a large deregulation cascade. Its high toxicity but sporadic expression constitutes major issues for testing emerging therapeutics. The IMEP method appeared as a convenient technique to locally express <jats:italic>DUX4<\/jats:italic> in mouse muscles. Histological analyses revealed well delineated muscle lesions 1-week after <jats:italic>DUX4<\/jats:italic> IMEP. We have therefore developed a convenient outcome measure by quantification of the damaged muscle area using color thresholding. This method was used to characterize lesion distribution and to assess plasmid recirculation and dose\u2013response. DUX4 expression and activity were confirmed at the mRNA and protein levels and through a quantification of target gene expression. Finally, this study gives a proof of concept of IMEP model usefulness for the rapid screening of therapeutic strategies, as demonstrated using antisense oligonucleotides against <jats:italic>DUX4<\/jats:italic> mRNA.<\/jats:p>","DOI":"10.1038\/s41598-020-68135-7","type":"journal-article","created":{"date-parts":[[2020,7,9]],"date-time":"2020-07-09T10:06:38Z","timestamp":1594289198000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Induction of a local muscular dystrophy using electroporation in vivo: an easy tool for screening therapeutics"],"prefix":"10.1038","volume":"10","author":[{"given":"Aline","family":"Derenne","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandra","family":"Tassin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thuy Hang","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Estelle","family":"De Roeck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincianne","family":"Jenart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eug\u00e9nie","family":"Ansseau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandra","family":"Belayew","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fr\u00e9d\u00e9rique","family":"Copp\u00e9e","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne-Emilie","family":"Decl\u00e8ves","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandre","family":"Legrand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,7,9]]},"reference":[{"key":"68135_CR1","doi-asserted-by":"publisher","first-page":"2776","DOI":"10.3390\/ijms20112776","volume":"20","author":"E Soko\u0142owska","year":"2019","unstructured":"Soko\u0142owska, E. & B\u0142achnio-Zabielska, A. U. A critical review of electroporation as a plasmid delivery system in mouse skeletal muscle. Int. J. Mol. Sci. 20, 2776. https:\/\/doi.org\/10.3390\/ijms20112776 (2019).","journal-title":"Int. J. Mol. Sci."},{"key":"68135_CR2","doi-asserted-by":"crossref","first-page":"3617","DOI":"10.1021\/acs.molpharmaceut.8b00207","volume":"15","author":"LD Cervia","year":"2018","unstructured":"Cervia, L. D. & Yuan, F. Current progress in electrotransfection as a nonviral method for gene delivery. Mol. Pharm. 15, 3617\u20133624 (2018).","journal-title":"Mol. Pharm."},{"key":"68135_CR3","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/bs.adgen.2014.10.003","volume":"89","author":"JL Young","year":"2015","unstructured":"Young, J. L. & Dean, D. A. Electroporation-mediated gene delivery. Adv. Genet. 89, 49\u201388 (2015).","journal-title":"Adv. Genet."},{"key":"68135_CR4","doi-asserted-by":"crossref","first-page":"98","DOI":"10.2174\/1566523216666160331130040","volume":"16","author":"C Rosazza","year":"2016","unstructured":"Rosazza, C., Meglic, S. H., Zumbusch, A., Rols, M.-P. & Miklavcic, D. Gene electrotransfer: A mechanistic perspective. Curr. Gene Ther. 16, 98\u2013129 (2016).","journal-title":"Curr. Gene Ther."},{"key":"68135_CR5","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1002\/j.1460-2075.1982.tb01257.x","volume":"1","author":"E Neumann","year":"1982","unstructured":"Neumann, E., Schaefer-Ridder, M., Wang, Y. & Hofschneider, P. H. Gene transfer into mouse lyoma cells by electroporation in high electric fields. EMBO J. 1, 841\u2013845 (1982).","journal-title":"EMBO J."},{"key":"68135_CR6","doi-asserted-by":"crossref","first-page":"2837","DOI":"10.1529\/biophysj.108.135541","volume":"95","author":"G Pucihar","year":"2008","unstructured":"Pucihar, G., Kotnik, T., Miklav\u010di\u010d, D. & Teissi\u00e9, J. Kinetics of transmembrane transport of small molecules into electropermeabilized cells. Biophys. J. 95, 2837\u20132848 (2008).","journal-title":"Biophys. J."},{"key":"68135_CR7","doi-asserted-by":"publisher","first-page":"3044","DOI":"10.3390\/molecules23113044","volume":"23","author":"J Shi","year":"2018","unstructured":"Shi, J. et al. A review on electroporation-based intracellular delivery. Molecules 23, 3044. https:\/\/doi.org\/10.3390\/molecules23113044 (2018).","journal-title":"Molecules"},{"key":"68135_CR8","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1007\/978-3-319-56895-9_5","volume":"227","author":"M Jakutavi\u010di\u016bt\u0117","year":"2017","unstructured":"Jakutavi\u010di\u016bt\u0117, M., Ruzgys, P., Tamo\u0161i\u016bnas, M., Maciulevi\u010dius, M. & \u0160atkauskas, S. Physical methods for drug and gene delivery through the cell plasma membrane. Adv. Anat. Embryol. Cell Biol. 227, 73\u201392 (2017).","journal-title":"Adv. Anat. Embryol. Cell Biol."},{"key":"68135_CR9","doi-asserted-by":"crossref","first-page":"2206","DOI":"10.1529\/biophysj.104.051268","volume":"88","author":"Y Antov","year":"2005","unstructured":"Antov, Y., Barbul, A., Mantsur, H. & Korenstein, R. Electroendocytosis: Exposure of cells to pulsed low electric fields enhances adsorption and uptake of macromolecules. Biophys. J. 88, 2206\u20132223 (2005).","journal-title":"Biophys. J."},{"key":"68135_CR10","doi-asserted-by":"crossref","first-page":"e286","DOI":"10.1038\/mtna.2015.59","volume":"5","author":"C Rosazza","year":"2016","unstructured":"Rosazza, C. et al. Endocytosis and endosomal trafficking of DNA after gene electrotransfer in vitro. Mol. Ther. Nucleic Acids 5, e286 (2016).","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"68135_CR11","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.bioelechem.2014.08.020","volume":"103","author":"B Markelc","year":"2015","unstructured":"Markelc, B. et al. Inhibitor of endocytosis impairs gene electrotransfer to mouse muscle in vivo. Bioelectrochemistry 103, 111\u2013119 (2015).","journal-title":"Bioelectrochemistry"},{"key":"68135_CR12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1177\/1533033818785329","volume":"17","author":"U Probst","year":"2018","unstructured":"Probst, U., Fuhrmann, I., Beyer, L. & Wiggermann, P. Electrochemotherapy as a new modality in interventional oncology: A review. Technol. Cancer Res. Treat. 17, 1\u201312. https:\/\/doi.org\/10.1177\/1533033818785329 (2018).","journal-title":"Technol. Cancer Res. Treat."},{"key":"68135_CR13","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.ejcsup.2006.08.002","volume":"4","author":"M Marty","year":"2006","unstructured":"Marty, M. et al. Electrochemotherapy\u2014An easy, highly effective and safe treatment of cutaneous and subcutaneous metastases: Results of ESOPE (European Standard Operating Procedures of Electrochemotherapy) study. Eur. J. Cancer Suppl. 4, 3\u201313 (2006).","journal-title":"Eur. J. Cancer Suppl."},{"key":"68135_CR14","doi-asserted-by":"publisher","DOI":"10.3791\/1038","author":"G Sersa","year":"2008","unstructured":"Sersa, G. & Miklavcic, D. Electrochemotherapy of tumours. J. Vis. Exp. https:\/\/doi.org\/10.3791\/1038 (2008).","journal-title":"J. Vis. Exp."},{"key":"68135_CR15","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/bs.adgen.2014.10.006","volume":"89","author":"R Heller","year":"2015","unstructured":"Heller, R. & Heller, L. C. Gene electrotransfer clinical trials. Adv. Genet. 89, 235\u2013262 (2015).","journal-title":"Adv. Genet."},{"key":"68135_CR16","doi-asserted-by":"crossref","first-page":"1694","DOI":"10.4161\/hv.22062","volume":"8","author":"A Gothelf","year":"2012","unstructured":"Gothelf, A. & Gehl, J. What you always needed to know about electroporation based DNA vaccines. Hum. Vaccin. Immunother. 8, 1694\u20131702 (2012).","journal-title":"Hum. Vaccin. Immunother."},{"key":"68135_CR17","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1586\/14760584.2015.1029919","volume":"14","author":"G Gr\u00f8deland","year":"2015","unstructured":"Gr\u00f8deland, G. & Bogen, B. Efficient vaccine against pandemic influenza: Combining DNA vaccination and targeted delivery to MHC class II molecules. Expert Rev. Vaccines 14, 805\u2013814 (2015).","journal-title":"Expert Rev. Vaccines"},{"key":"68135_CR18","doi-asserted-by":"publisher","first-page":"96","DOI":"10.3390\/vaccines7030096","volume":"7","author":"Z Zhong","year":"2019","unstructured":"Zhong, Z. et al. Immunogenicity and protection efficacy of a naked self-replicating mRNA-based Zika virus vaccine. Vaccines (Basel) 7, 96. https:\/\/doi.org\/10.3390\/vaccines7030096 (2019).","journal-title":"Vaccines (Basel)"},{"key":"68135_CR19","doi-asserted-by":"crossref","first-page":"4444","DOI":"10.1016\/j.vaccine.2019.06.083","volume":"37","author":"M Williams","year":"2019","unstructured":"Williams, M. et al. Enhanced immunogenicity and protective efficacy of a tetravalent dengue DNA vaccine using electroporation and intradermal delivery. Vaccine 37, 4444\u20134453 (2019).","journal-title":"Vaccine"},{"key":"68135_CR20","doi-asserted-by":"crossref","first-page":"4872","DOI":"10.1016\/j.vaccine.2012.04.078","volume":"30","author":"MT Albrecht","year":"2012","unstructured":"Albrecht, M. T. et al. Electroporation of a multivalent DNA vaccine cocktail elicits a protective immune response against anthrax and plague. Vaccine 30, 4872\u20134883 (2012).","journal-title":"Vaccine"},{"key":"68135_CR21","doi-asserted-by":"crossref","first-page":"5896","DOI":"10.1200\/JCO.2007.15.6794","volume":"26","author":"AI Daud","year":"2008","unstructured":"Daud, A. I. et al. Phase I trial of interleukin-12 plasmid electroporation in patients with metastatic melanoma. J. Clin. Oncol. 26, 5896\u20135903 (2008).","journal-title":"J. Clin. Oncol."},{"key":"68135_CR22","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1186\/s40425-019-0638-5","volume":"7","author":"L Pasquet","year":"2019","unstructured":"Pasquet, L. et al. Pre-clinical investigation of the synergy effect of interleukin-12 gene-electro-transfer during partially irreversible electropermeabilization against melanoma. J. Immunother. Cancer 7, 161 (2019).","journal-title":"J. Immunother. Cancer"},{"key":"68135_CR23","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1111\/j.1523-1755.2004.00777.x","volume":"66","author":"Y Isaka","year":"2004","unstructured":"Isaka, Y. et al. DNAzyme for TGF-beta suppressed extracellular matrix accumulation in experimental glomerulonephritis. Kidney Int. 66, 586\u2013590 (2004).","journal-title":"Kidney Int."},{"key":"68135_CR24","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1038\/sj.gt.3302951","volume":"14","author":"P Hojman","year":"2007","unstructured":"Hojman, P., Gissel, H. & Gehl, J. Sensitive and precise regulation of haemoglobin after gene transfer of erythropoietin to muscle tissue using electroporation. Gene Ther. 14, 950\u2013959 (2007).","journal-title":"Gene Ther."},{"key":"68135_CR25","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1038\/gt.2010.46","volume":"17","author":"A Gothelf","year":"2010","unstructured":"Gothelf, A., Hojman, P. & Gehl, J. Therapeutic levels of erythropoietin (EPO) achieved after gene electrotransfer to skin in mice. Gene Ther. 17, 1077\u20131084 (2010).","journal-title":"Gene Ther."},{"key":"68135_CR26","doi-asserted-by":"crossref","first-page":"e14467","DOI":"10.1371\/journal.pone.0014467","volume":"5","author":"EL Ayuni","year":"2010","unstructured":"Ayuni, E. L. et al. In vivo electroporation mediate****d gene delivery to the beating heart. PLoS\u00a0One 5, e14467 (2010).","journal-title":"PLoS\u00a0One"},{"key":"68135_CR27","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1038\/nm.3793","volume":"21","author":"DBT Cox","year":"2015","unstructured":"Cox, D. B. T., Platt, R. J. & Zhang, F. Therapeutic genome editing: Prospects and challenges. Nat. Med. 21, 121\u2013131 (2015).","journal-title":"Nat. Med."},{"key":"68135_CR28","doi-asserted-by":"crossref","first-page":"e389","DOI":"10.1038\/mtna.2016.92","volume":"5","author":"MC Latella","year":"2016","unstructured":"Latella, M. C. et al. In vivo editing of the human mutant rhodopsin gene by electroporation of plasmid-based CRISPR\/Cas9 in the mouse retina. Mol. Ther. Nucleic Acids 5, e389 (2016).","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"68135_CR29","doi-asserted-by":"crossref","first-page":"e232","DOI":"10.1038\/emm.2016.27","volume":"48","author":"M-Y Son","year":"2016","unstructured":"Son, M.-Y. et al. Generation and characterization of integration-free induced pluripotent stem cells from patients with autoimmune disease. Exp. Mol. Med. 48, e232 (2016).","journal-title":"Exp. Mol. Med."},{"key":"68135_CR30","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1038\/nmeth.1591","volume":"8","author":"K Okita","year":"2011","unstructured":"Okita, K. et al. A more efficient method to generate integration-free human iPS cells. Nat. Methods 8, 409\u2013412 (2011).","journal-title":"Nat. Methods"},{"key":"68135_CR31","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1038\/nrg1066","volume":"4","author":"CE Thomas","year":"2003","unstructured":"Thomas, C. E., Ehrhardt, A. & Kay, M. A. Progress and problems with the use of viral vectors for gene therapy. Nat. Rev. Genet. 4, 346\u2013358 (2003).","journal-title":"Nat. Rev. Genet."},{"key":"68135_CR32","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1038\/sj.gt.3301412","volume":"8","author":"H Maruyama","year":"2001","unstructured":"Maruyama, H. et al. Long-term production of erythropoietin after electroporation-mediated transfer of plasmid DNA into the muscles of normal and uremic rats. Gene Ther. 8, 461\u2013468 (2001).","journal-title":"Gene Ther."},{"key":"68135_CR33","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1002\/jgm.683","volume":"7","author":"YC Long","year":"2005","unstructured":"Long, Y. C. et al. FVIII gene delivery by muscle electroporation corrects murine hemophilia A. J. Gene Med. 7, 494\u2013505 (2005).","journal-title":"J. Gene Med."},{"key":"68135_CR34","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1038\/sj.cgt.7700287","volume":"8","author":"E Hanna","year":"2001","unstructured":"Hanna, E. et al. Intramuscular electroporation delivery of IL-12 gene for treatment of squamous cell carcinoma located at distant site. Cancer Gene Ther. 8, 151\u2013157 (2001).","journal-title":"Cancer Gene Ther."},{"key":"68135_CR35","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1038\/nbt0998-867","volume":"16","author":"H Aihara","year":"1998","unstructured":"Aihara, H. & Miyazaki, J. Gene transfer into muscle by electroporation in vivo. Nat. Biotechnol. 16, 867\u2013870 (1998).","journal-title":"Nat. Biotechnol."},{"key":"68135_CR36","first-page":"342","volume":"4","author":"T Akerstrom","year":"2015","unstructured":"Akerstrom, T. et al. Optimizing hyaluronidase dose and plasmid DNA delivery greatly improves gene electrotransfer efficiency in rat skeletal muscle. Biochem. Biophys. Rep. 4, 342\u2013350 (2015).","journal-title":"Biochem. Biophys. Rep."},{"key":"68135_CR37","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1006\/mthe.2001.0483","volume":"4","author":"J Hartikka","year":"2001","unstructured":"Hartikka, J. et al. Electroporation-facilitated delivery of plasmid DNA in skeletal muscle: Plasmid dependence of muscle damage and effect of poloxamer 188. Mol. Ther. 4, 407\u2013415 (2001).","journal-title":"Mol. Ther."},{"key":"68135_CR38","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/1472-6750-4-11","volume":"4","author":"J Taylor","year":"2004","unstructured":"Taylor, J. et al. Optimization of ectopic gene expression in skeletal muscle through DNA transfer by electroporation. BMC Biotechnol. 4, 11 (2004).","journal-title":"BMC Biotechnol."},{"key":"68135_CR39","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1038\/sj.gt.3301522","volume":"8","author":"JM McMahon","year":"2001","unstructured":"McMahon, J. M., Signori, E., Wells, K. E., Fazio, V. M. & Wells, D. J. Optimisation of electrotransfer of plasmid into skeletal muscle by pretreatment with hyaluronidase\u2014increased expression with reduced muscle damage. Gene Ther. 8, 1264\u20131270 (2001).","journal-title":"Gene Ther."},{"key":"68135_CR40","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/j.ymthe.2004.06.642","volume":"10","author":"MJ Molnar","year":"2004","unstructured":"Molnar, M. J. et al. Factors influencing the efficacy, longevity, and safety of electroporation-assisted plasmid-based gene transfer into mouse muscles. Mol. Ther. 10, 447\u2013455 (2004).","journal-title":"Mol. Ther."},{"key":"68135_CR41","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1038\/sj.gt.3301484","volume":"8","author":"JT Vilquin","year":"2001","unstructured":"Vilquin, J. T. et al. Electrotransfer of naked DNA in the skeletal muscles of animal models of muscular dystrophies. Gene Ther. 8, 1097\u20131107 (2001).","journal-title":"Gene Ther."},{"key":"68135_CR42","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1089\/hum.2010.024","volume":"21","author":"C Pichavant","year":"2010","unstructured":"Pichavant, C., Chapdelaine, P., Cerri, D. G., Bizario, J. C. S. & Tremblay, J. P. Electrotransfer of the full-length dog dystrophin into mouse and dystrophic dog muscles. Hum. Gene Ther. 21, 1591\u20131601 (2010).","journal-title":"Hum. Gene Ther."},{"key":"68135_CR43","first-page":"1916","volume":"22","author":"JM Statland","year":"2016","unstructured":"Statland, J. M. & Tawil, R. Facioscapulohumeral muscular dystrophy. Continuum (Minneap Minn) 22, 1916\u20131931 (2016).","journal-title":"Continuum (Minneap Minn)"},{"key":"68135_CR44","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1016\/0140-6736(90)92148-B","volume":"336","author":"C Wijmenga","year":"1990","unstructured":"Wijmenga, C. et al. Location of facioscapulohumeral muscular dystrophy gene on chromosome 4. Lancet 336, 651\u2013653 (1990).","journal-title":"Lancet"},{"key":"68135_CR45","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1016\/0888-7543(91)90348-I","volume":"9","author":"C Wijmenga","year":"1991","unstructured":"Wijmenga, C. et al. Mapping of facioscapulohumeral muscular dystrophy gene to chromosome 4q35-qter by multipoint linkage analysis and in situ hybridization. Genomics 9, 570\u2013575 (1991).","journal-title":"Genomics"},{"key":"68135_CR46","doi-asserted-by":"crossref","first-page":"2037","DOI":"10.1093\/hmg\/2.12.2037","volume":"2","author":"JC van Deutekom","year":"1993","unstructured":"van Deutekom, J. C. et al. FSHD associated DNA rearrangements are due to deletions of integral copies of a 3.2 kb tandemly repeated unit. Hum. Mol. Genet. 2, 2037\u20132042 (1993).","journal-title":"Hum. Mol. Genet."},{"key":"68135_CR47","doi-asserted-by":"crossref","first-page":"e0160022","DOI":"10.1371\/journal.pone.0160022","volume":"11","author":"S Das","year":"2016","unstructured":"Das, S. & Chadwick, B. P. Influence of repressive histone and DNA methylation upon D4Z4 transcription in non-myogenic cells. PLoS\u00a0One 11, e0160022 (2016).","journal-title":"PLoS\u00a0One"},{"key":"68135_CR48","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1038\/ng999","volume":"32","author":"RJLF Lemmers","year":"2002","unstructured":"Lemmers, R. J. L. F. et al. Facioscapulohumeral muscular dystrophy is uniquely associated with one of the two variants of the 4q subtelomere. Nat. Genet. 32, 235\u2013236 (2002).","journal-title":"Nat. Genet."},{"key":"68135_CR49","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1086\/521986","volume":"81","author":"RJLF Lemmers","year":"2007","unstructured":"Lemmers, R. J. L. F. et al. Specific sequence variations within the 4q35 region are associated with facioscapulohumeral muscular dystrophy. Am. J. Hum. Genet. 81, 884\u2013894 (2007).","journal-title":"Am. J. Hum. Genet."},{"key":"68135_CR50","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1126\/science.1189044","volume":"329","author":"RJLF Lemmers","year":"2010","unstructured":"Lemmers, R. J. L. F. et al. A unifying genetic model for facioscapulohumeral muscular dystrophy. Science 329, 1650\u20131653 (2010).","journal-title":"Science"},{"key":"68135_CR51","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1038\/ng.2454","volume":"44","author":"RJLF Lemmers","year":"2012","unstructured":"Lemmers, R. J. L. F. et al. Digenic inheritance of an SMCHD1 mutation and an FSHD-permissive D4Z4 allele causes facioscapulohumeral muscular dystrophy type 2. Nat. Genet. 44, 1370\u20131374 (2012).","journal-title":"Nat. Genet."},{"key":"68135_CR52","doi-asserted-by":"crossref","first-page":"e1001181","DOI":"10.1371\/journal.pgen.1001181","volume":"6","author":"L Snider","year":"2010","unstructured":"Snider, L. et al. Facioscapulohumeral dystrophy: incomplete suppression of a retrotransposed gene. PLoS Genet. 6, e1001181 (2010).","journal-title":"PLoS Genet."},{"key":"68135_CR53","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.devcel.2011.11.013","volume":"22","author":"LN Geng","year":"2012","unstructured":"Geng, L. N. et al. DUX4 activates germline genes, retroelements and immune-mediators: Implications for facioscapulohumeral dystrophy. Dev. Cell 22, 38\u201351 (2012).","journal-title":"Dev. Cell"},{"key":"68135_CR54","doi-asserted-by":"crossref","first-page":"e26820","DOI":"10.1371\/journal.pone.0026820","volume":"6","author":"C Vanderplanck","year":"2011","unstructured":"Vanderplanck, C. et al. The FSHD atrophic myotube phenotype is caused by DUX4 expression. PLoS\u00a0One 6, e26820 (2011).","journal-title":"PLoS\u00a0One"},{"key":"68135_CR55","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1111\/j.1582-4934.2012.01647.x","volume":"17","author":"A Tassin","year":"2013","unstructured":"Tassin, A. et al. DUX4 expression in FSHD muscle cells: How could such a rare protein cause a myopathy?. J. Cell. Mol. Med. 17, 76\u201389 (2013).","journal-title":"J. Cell. Mol. Med."},{"key":"68135_CR56","doi-asserted-by":"crossref","first-page":"e04996","DOI":"10.7554\/eLife.04996","volume":"4","author":"Q Feng","year":"2015","unstructured":"Feng, Q. et al. A feedback loop between nonsense-mediated decay and the retrogene DUX4 in facioscapulohumeral muscular dystrophy. eLife 4, e04996 (2015).","journal-title":"eLife"},{"key":"68135_CR57","doi-asserted-by":"crossref","first-page":"e1006658","DOI":"10.1371\/journal.pgen.1006658","volume":"13","author":"SC Shadle","year":"2017","unstructured":"Shadle, S. C. et al. DUX4-induced dsRNA and MYC mRNA stabilization activate apoptotic pathways in human cell models of facioscapulohumeral dystrophy. PLoS Genet. 13, e1006658 (2017).","journal-title":"PLoS Genet."},{"key":"68135_CR58","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/j.nmd.2007.04.002","volume":"17","author":"V Kowaljow","year":"2007","unstructured":"Kowaljow, V. et al. The DUX4 gene at the FSHD1A locus encodes a pro-apoptotic protein. Neuromuscul. Disord. 17, 611\u2013623 (2007).","journal-title":"Neuromuscul. Disord."},{"key":"68135_CR59","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1002\/ana.22275","volume":"69","author":"LM Wallace","year":"2011","unstructured":"Wallace, L. M. et al. DUX4, a candidate gene for facioscapulohumeral muscular dystrophy, causes p53-dependent myopathy in vivo. Ann. Neurol. 69, 540\u2013552 (2011).","journal-title":"Ann. Neurol."},{"key":"68135_CR60","doi-asserted-by":"crossref","first-page":"5901","DOI":"10.1093\/hmg\/ddv315","volume":"24","author":"AM Rickard","year":"2015","unstructured":"Rickard, A. M., Petek, L. M. & Miller, D. G. Endogenous DUX4 expression in FSHD myotubes is sufficient to cause cell death and disrupts RNA splicing and cell migration pathways. Hum. Mol. Genet. 24, 5901\u20135914 (2015).","journal-title":"Hum. Mol. Genet."},{"key":"68135_CR61","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1212\/WNL.48.1.46","volume":"48","author":"R Tawil","year":"1997","unstructured":"Tawil, R. et al. A pilot trial of prednisone in facioscapulohumeral muscular dystrophy. FSH-DY Group. Neurology 48, 46\u201349 (1997).","journal-title":"Neurology"},{"key":"68135_CR62","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1212\/WNL.57.8.1434","volume":"57","author":"JT Kissel","year":"2001","unstructured":"Kissel, J. T. et al. Randomized, double-blind, placebo-controlled trial of albuterol in facioscapulohumeral dystrophy. Neurology 57, 1434\u20131440 (2001).","journal-title":"Neurology"},{"key":"68135_CR63","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1212\/01.WNL.0000134660.30793.1F","volume":"63","author":"EL van der Kooi","year":"2004","unstructured":"van der Kooi, E. L. et al. Strength training and albuterol in facioscapulohumeral muscular dystrophy. Neurology 63, 702\u2013708 (2004).","journal-title":"Neurology"},{"key":"68135_CR64","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1016\/j.apmr.2008.12.027","volume":"90","author":"CA Payan","year":"2009","unstructured":"Payan, C. A. et al. Periodic salbutamol in facioscapulohumeral muscular dystrophy: A randomized controlled trial. Arch. Phys. Med. Rehabil. 90, 1094\u20131101 (2009).","journal-title":"Arch. Phys. Med. Rehabil."},{"key":"68135_CR65","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1007\/s00415-006-0432-4","volume":"254","author":"EL van der Kooi","year":"2007","unstructured":"van der Kooi, E. L. et al. Effects of training and albuterol on pain and fatigue in facioscapulohumeral muscular dystrophy. J. Neurol. 254, 931\u2013940 (2007).","journal-title":"J. Neurol."},{"key":"68135_CR66","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.freeradbiomed.2014.09.014","volume":"81","author":"E Passerieux","year":"2015","unstructured":"Passerieux, E. et al. Effects of vitamin C, vitamin E, zinc gluconate, and selenomethionine supplementation on muscle function and oxidative stress biomarkers in patients with facioscapulohumeral dystrophy: A double-blind randomized controlled clinical trial. Free Radic. Biol. Med. 81, 158\u2013169 (2015).","journal-title":"Free Radic. Biol. Med."},{"key":"68135_CR67","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1124\/jpet.119.259663","volume":"370","author":"J Oliva","year":"2019","unstructured":"Oliva, J. et al. Clinically advanced p38 inhibitors suppress DUX4 expression in cellular and animal models of facioscapulohumeral muscular dystrophy. J. Pharmacol. Exp. Ther. 370, 219\u2013230 (2019).","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"68135_CR68","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1007\/s13311-018-00675-3","volume":"15","author":"J Hamel","year":"2018","unstructured":"Hamel, J. & Tawil, R. Facioscapulohumeral muscular dystrophy: Update on pathogenesis and future treatments. Neurotherapeutics 15, 863\u2013871 (2018).","journal-title":"Neurotherapeutics"},{"key":"68135_CR69","doi-asserted-by":"crossref","first-page":"168","DOI":"10.5582\/irdr.2016.01056","volume":"5","author":"B Bao","year":"2016","unstructured":"Bao, B., Maruyama, R. & Yokota, T. Targeting mRNA for the treatment of facioscapulohumeral muscular dystrophy. Intractable Rare Dis. Res. 5, 168\u2013176 (2016).","journal-title":"Intractable Rare Dis. Res."},{"key":"68135_CR70","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1080\/15592294.2015.1113798","volume":"10","author":"J Balog","year":"2015","unstructured":"Balog, J. et al. Increased DUX4 expression during muscle differentiation correlates with decreased SMCHD1 protein levels at D4Z4. Epigenetics 10, 1133\u20131142 (2015).","journal-title":"Epigenetics"},{"key":"68135_CR71","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.31023","author":"AE Campbell","year":"2018","unstructured":"Campbell, A. E. et al. NuRD and CAF-1-mediated silencing of the D4Z4 array is modulated by DUX4-induced MBD3L proteins. Elife https:\/\/doi.org\/10.7554\/eLife.31023 (2018).","journal-title":"Elife"},{"key":"68135_CR72","doi-asserted-by":"publisher","first-page":"93","DOI":"10.3390\/genes8030093","volume":"8","author":"E Ansseau","year":"2017","unstructured":"Ansseau, E. et al. Antisense oligonucleotides used to target the DUX4 mRNA as therapeutic approaches in faciosscapulohumeral muscular dystrophy (FSHD). Genes (Basel) 8, 93. https:\/\/doi.org\/10.3390\/genes8030093 (2017).","journal-title":"Genes (Basel)"},{"key":"68135_CR73","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1038\/mt.2016.111","volume":"24","author":"JC Chen","year":"2016","unstructured":"Chen, J. C. et al. Morpholino-mediated knockdown of DUX4 toward facioscapulohumeral muscular dystrophy therapeutics. Mol. Ther. 24, 1405\u20131411 (2016).","journal-title":"Mol. Ther."},{"key":"68135_CR74","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.omtm.2017.12.005","volume":"8","author":"LM Wallace","year":"2018","unstructured":"Wallace, L. M. et al. Pre-clinical safety and off-target studies to support translation of AAV-mediated RNAi therapy for FSHD. Mol. Ther. Methods Clin. Dev. 8, 121\u2013130 (2018).","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"68135_CR75","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1038\/mt.2012.68","volume":"20","author":"LM Wallace","year":"2012","unstructured":"Wallace, L. M. et al. RNA interference inhibits DUX4-induced muscle toxicity in vivo: Implications for a targeted FSHD therapy. Mol. Ther. 20, 1417\u20131423 (2012).","journal-title":"Mol. Ther."},{"key":"68135_CR76","doi-asserted-by":"crossref","first-page":"e1003415","DOI":"10.1371\/journal.pgen.1003415","volume":"9","author":"YD Krom","year":"2013","unstructured":"Krom, Y. D. et al. Intrinsic epigenetic regulation of the D4Z4 macrosatellite repeat in a transgenic mouse model for FSHD. PLoS Genet. 9, e1003415 (2013).","journal-title":"PLoS Genet."},{"key":"68135_CR77","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.1016\/j.celrep.2014.07.056","volume":"8","author":"A Dandapat","year":"2014","unstructured":"Dandapat, A. et al. Dominant lethal pathologies in male mice engineered to contain an X-linked DUX4 transgene. Cell. Rep. 8, 1484\u20131496 (2014).","journal-title":"Cell. Rep."},{"key":"68135_CR78","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1038\/s41467-017-00730-1","volume":"8","author":"D Bosnakovski","year":"2017","unstructured":"Bosnakovski, D. et al. Muscle pathology from stochastic low level DUX4 expression in an FSHD mouse model. Nat. Commun. 8, 550 (2017).","journal-title":"Nat. Commun."},{"key":"68135_CR79","doi-asserted-by":"crossref","first-page":"e0192657","DOI":"10.1371\/journal.pone.0192657","volume":"13","author":"T Jones","year":"2018","unstructured":"Jones, T. & Jones, P. L. A cre-inducible DUX4 transgenic mouse model for investigating facioscapulohumeral muscular dystrophy. PLoS\u00a0One 13, e0192657 (2018).","journal-title":"PLoS\u00a0One"},{"key":"68135_CR80","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1172\/jci.insight.123538","volume":"3","author":"CR Giesige","year":"2018","unstructured":"Giesige, C. R. et al. AAV-mediated follistatin gene therapy improves functional outcomes in the TIC-DUX4 mouse model of FSHD. JCI Insight 3, 22. https:\/\/doi.org\/10.1172\/jci.insight.123538 (2018).","journal-title":"JCI Insight"},{"key":"68135_CR81","doi-asserted-by":"crossref","first-page":"113011","DOI":"10.1016\/j.expneurol.2019.113011","volume":"320","author":"AL Mueller","year":"2019","unstructured":"Mueller, A. L. et al. Muscle xenografts reproduce key molecular features of facioscapulohumeral muscular dystrophy. Exp. Neurol. 320, 113011 (2019).","journal-title":"Exp. Neurol."},{"key":"68135_CR82","doi-asserted-by":"crossref","first-page":"3180","DOI":"10.1093\/hmg\/ddu028","volume":"23","author":"Y Zhang","year":"2014","unstructured":"Zhang, Y. et al. Human skeletal muscle xenograft as a new preclinical model for muscle disorders. Hum. Mol. Genet. 23, 3180\u20133188 (2014).","journal-title":"Hum. Mol. Genet."},{"key":"68135_CR83","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/s13395-020-00227-4","volume":"10","author":"TI Jones","year":"2020","unstructured":"Jones, T. I. et al. Transgenic mice expressing tunable levels of DUX4 develop characteristic facioscapulohumeral muscular dystrophy-like pathophysiology ranging in severity. Skelet. Muscle 10, 8 (2020).","journal-title":"Skelet. Muscle"},{"key":"68135_CR84","doi-asserted-by":"crossref","first-page":"2766","DOI":"10.1038\/emboj.2008.201","volume":"27","author":"D Bosnakovski","year":"2008","unstructured":"Bosnakovski, D. et al. An isogenetic myoblast expression screen identifies DUX4-mediated FSHD-associated molecular pathologies. EMBO J. 27, 2766\u20132779 (2008).","journal-title":"EMBO J."},{"key":"68135_CR85","doi-asserted-by":"crossref","first-page":"e64691","DOI":"10.1371\/journal.pone.0064691","volume":"8","author":"V Sharma","year":"2013","unstructured":"Sharma, V., Harafuji, N., Belayew, A. & Chen, Y.-W. DUX4 differentially regulates transcriptomes of human rhabdomyosarcoma and mouse C2C12 cells. PLoS\u00a0One 8, e64691 (2013).","journal-title":"PLoS\u00a0One"},{"key":"68135_CR86","doi-asserted-by":"crossref","first-page":"16957","DOI":"10.1038\/s41598-018-35150-8","volume":"8","author":"D Bosnakovski","year":"2018","unstructured":"Bosnakovski, D. et al. Low level DUX4 expression disrupts myogenesis through deregulation of myogenic gene expression. Sci. Rep. 8, 16957 (2018).","journal-title":"Sci. Rep."},{"key":"68135_CR87","doi-asserted-by":"crossref","first-page":"e0118813","DOI":"10.1371\/journal.pone.0118813","volume":"10","author":"E Ansseau","year":"2015","unstructured":"Ansseau, E. et al. Aberrant splicing in transgenes containing introns, exons, and V5 epitopes: Lessons from developing an FSHD mouse model expressing a D4Z4 repeat with flanking genomic sequences. PLoS\u00a0One 10, e0118813 (2015).","journal-title":"PLoS\u00a0One"},{"key":"68135_CR88","first-page":"201","volume":"3","author":"MY Levy","year":"1996","unstructured":"Levy, M. Y., Barron, L. G., Meyer, K. B. & Szoka, F. C. Characterization of plasmid DNA transfer into mouse skeletal muscle: Evaluation of uptake mechanism, expression and secretion of gene products into blood. Gene Ther. 3, 201\u2013211 (1996).","journal-title":"Gene Ther."},{"key":"68135_CR89","doi-asserted-by":"crossref","first-page":"4262","DOI":"10.1073\/pnas.96.8.4262","volume":"96","author":"LM Mir","year":"1999","unstructured":"Mir, L. M. et al. High-efficiency gene transfer into skeletal muscle mediated by electric pulses. Proc. Natl. Acad. Sci. USA 96, 4262\u20134267 (1999).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"68135_CR90","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1016\/j.ymthe.2005.09.019","volume":"13","author":"JD Schertzer","year":"2006","unstructured":"Schertzer, J. D., Plant, D. R. & Lynch, G. S. Optimizing plasmid-based gene transfer for investigating skeletal muscle structure and function. Mol. Ther. 13, 795\u2013803 (2006).","journal-title":"Mol. Ther."},{"key":"68135_CR91","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1006\/mthe.2000.0117","volume":"2","author":"M Bettan","year":"2000","unstructured":"Bettan, M. et al. High-level protein secretion into blood circulation after electric pulse-mediated gene transfer into skeletal muscle. Mol. Ther. 2, 204\u2013210 (2000).","journal-title":"Mol. Ther."},{"key":"68135_CR92","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/S0304-4165(99)00094-X","volume":"1428","author":"J Gehl","year":"1999","unstructured":"Gehl, J. et al. In vivo electroporation of skeletal muscle: Threshold, efficacy and relation to electric field distribution. Biochim. Biophys. Acta 1428, 233\u2013240 (1999).","journal-title":"Biochim. Biophys. Acta"},{"key":"68135_CR93","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1006\/bbrc.1999.1014","volume":"261","author":"J Gehl","year":"1999","unstructured":"Gehl, J. & Mir, L. M. Determination of optimal parameters for in vivo gene transfer by electroporation, using a rapid in vivo test for cell permeabilization. Biochem. Biophys. Res. Commun. 261, 377\u2013380 (1999).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"68135_CR94","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1038\/sj.gt.3301256","volume":"7","author":"D Favre","year":"2000","unstructured":"Favre, D. et al. Hyaluronidase enhances recombinant adeno-associated virus (rAAV)-mediated gene transfer in the rat skeletal muscle. Gene Ther. 7, 1417\u20131420 (2000).","journal-title":"Gene Ther."},{"key":"68135_CR95","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1089\/hum.2011.073","volume":"23","author":"M Cemazar","year":"2012","unstructured":"Cemazar, M. et al. Hyaluronidase and collagenase increase the transfection efficiency of gene electrotransfer in various murine tumors. Hum. Gene Ther. 23, 128\u2013137 (2012).","journal-title":"Hum. Gene Ther."},{"key":"68135_CR96","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1089\/10430340252792495","volume":"13","author":"C Mennuni","year":"2002","unstructured":"Mennuni, C. et al. Hyaluronidase increases electrogene transfer efficiency in skeletal muscle. Hum. Gene Ther. 13, 355\u2013365 (2002).","journal-title":"Hum. Gene Ther."},{"key":"68135_CR97","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1038\/sj.bjc.6602626","volume":"93","author":"L Eikenes","year":"2005","unstructured":"Eikenes, L., Tari, M., Tufto, I., Bruland, O. S. & de LangeDavies, C. Hyaluronidase induces a transcapillary pressure gradient and improves the distribution and uptake of liposomal doxorubicin (Caelyx) in human osteosarcoma xenografts. Br. J. Cancer 93, 81\u201388 (2005).","journal-title":"Br. J. Cancer"},{"key":"68135_CR98","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1038\/s41422-019-0238-4","volume":"29","author":"M Guo","year":"2019","unstructured":"Guo, M. et al. Precise temporal regulation of Dux is important for embryo development. Cell Res. 29, 956\u2013959 (2019).","journal-title":"Cell Res."},{"key":"68135_CR99","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.cell.2018.05.043","volume":"174","author":"M Percharde","year":"2018","unstructured":"Percharde, M. et al. A LINE1-nucleolin partnership regulates early development and ESC identity. Cell 174, 391-405.e19 (2018).","journal-title":"Cell"},{"key":"68135_CR100","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1007\/s11693-011-9089-0","volume":"5","author":"JP Ferreira","year":"2011","unstructured":"Ferreira, J. P., Peacock, R. W. S., Lawhorn, I. E. B. & Wang, C. L. Modulating ectopic gene expression levels by using retroviral vectors equipped with synthetic promoters. Syst. Synth. Biol. 5, 131\u2013138 (2011).","journal-title":"Syst. Synth. Biol."},{"key":"68135_CR101","doi-asserted-by":"crossref","first-page":"4661","DOI":"10.1093\/hmg\/ddt314","volume":"22","author":"GJ Block","year":"2013","unstructured":"Block, G. J. et al. Wnt\/\u03b2-catenin signaling suppresses DUX4 expression and prevents apoptosis of FSHD muscle cells. Hum. Mol. Genet. 22, 4661\u20134672 (2013).","journal-title":"Hum. Mol. Genet."},{"key":"68135_CR102","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1093\/hmg\/ddt409","volume":"23","author":"M Ferreboeuf","year":"2014","unstructured":"Ferreboeuf, M. et al. DUX4 and DUX4 downstream target genes are expressed in fetal FSHD muscles. Hum. Mol. Genet. 23, 171\u2013181 (2014).","journal-title":"Hum. Mol. Genet."},{"key":"68135_CR103","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1016\/j.freeradbiomed.2012.06.041","volume":"53","author":"A Turki","year":"2012","unstructured":"Turki, A. et al. Functional muscle impairment in facioscapulohumeral muscular dystrophy is correlated with oxidative stress and mitochondrial dysfunction. Free Radic. Biol. Med. 53, 1068\u20131079 (2012).","journal-title":"Free Radic. Biol. Med."},{"key":"68135_CR104","doi-asserted-by":"crossref","first-page":"e75614","DOI":"10.1371\/journal.pone.0075614","volume":"8","author":"ED Corona","year":"2013","unstructured":"Corona, E. D., Jacquelin, D., Gatica, L. & Rosa, A. L. Multiple protein domains contribute to nuclear import and cell toxicity of DUX4, a candidate pathogenic protein for facioscapulohumeral muscular dystrophy. PLoS\u00a0One 8, e75614 (2013).","journal-title":"PLoS\u00a0One"},{"key":"68135_CR105","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/0014-5793(94)80621-7","volume":"337","author":"T Ono","year":"1994","unstructured":"Ono, T. et al. Limited diffusibility of gene products directed by a single nucleus in the cytoplasm of multinucleated myofibres. FEBS Lett. 337, 18\u201322 (1994).","journal-title":"FEBS Lett."},{"key":"68135_CR106","doi-asserted-by":"crossref","first-page":"2748","DOI":"10.1101\/gad.12.17.2748","volume":"12","author":"S Newlands","year":"1998","unstructured":"Newlands, S. et al. Transcription occurs in pulses in muscle fibers. Genes Dev. 12, 2748\u20132758 (1998).","journal-title":"Genes Dev."},{"key":"68135_CR107","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1089\/hgtb.2012.173","volume":"23","author":"I Spanggaard","year":"2012","unstructured":"Spanggaard, I. et al. Spatial distribution of transgenic protein after gene electrotransfer to porcine muscle. Hum. Gene Ther. Methods 23, 387\u2013392 (2012).","journal-title":"Hum. Gene Ther. Methods"},{"key":"68135_CR108","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1089\/hum.2010.160","volume":"22","author":"CI Wooddell","year":"2011","unstructured":"Wooddell, C. I. et al. Dose response in rodents and nonhuman primates after hydrodynamic limb vein delivery of naked plasmid DNA. Hum. Gene Ther. 22, 889\u2013903 (2011).","journal-title":"Hum. Gene Ther."},{"key":"68135_CR109","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1016\/j.ymthe.2004.05.004","volume":"10","author":"JE Hagstrom","year":"2004","unstructured":"Hagstrom, J. E. et al. A facile nonviral method for delivering genes and siRNAs to skeletal muscle of mammalian limbs. Mol. Ther. 10, 386\u2013398 (2004).","journal-title":"Mol. Ther."},{"key":"68135_CR110","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S0378-1119(99)00267-X","volume":"236","author":"J Gabri\u00ebls","year":"1999","unstructured":"Gabri\u00ebls, J. et al. Nucleotide sequence of the partially deleted D4Z4 locus in a patient with FSHD identifies a putative gene within each 3.3 kb element. Gene 236, 25\u201332 (1999).","journal-title":"Gene"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-68135-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-68135-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-68135-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,6]],"date-time":"2022-12-06T13:40:03Z","timestamp":1670334003000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-68135-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7,9]]},"references-count":110,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2020,12]]}},"alternative-id":["68135"],"URL":"https:\/\/doi.org\/10.1038\/s41598-020-68135-7","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,7,9]]},"assertion":[{"value":"1 February 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 June 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 July 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest. However, regarding the experiment involving an antisense oligonucleotide (vPMO pLAM3A \u221212\u2009+\u200913), we have to mention that FC, EA and AB are co-inventors on patent US2012225034A1.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"11301"}}